Cohance Lifesciences457.80
-3.05 (-0.66%)

Cohance Lifesciences Share Price

457.80-3.05 (-0.66%)
-49.41% past 1 Year

Cohance Lifesciences is a fully integrated global CDMO, partnering with leading innovators across the entire product lifecycle- from route scouting and early development to commercial manufacturing. With advanced capabilities in

Corporate filings & documents

Announcements

Press Release
19 hours ago
Press Release
19 hours ago
Outcome of Committee Meeting
19 hours ago
Outcome of Committee Meeting
19 hours ago
Investors Meet
1 week ago
Investors Meet
1 week ago
Newspaper Publication
1 week ago
Newspaper Publication
1 week ago
BRSR
1 week ago
BRSR
1 week ago
Annual Report 2026
1 week ago
Annual Report 2026
1 week ago
Notice of AGM 2026
1 week ago
Notice of AGM 2026
1 week ago
Credit Rating
3 weeks ago
Credit Rating
3 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd
3 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd
3 weeks ago
Earnings Call Transcript
3 weeks ago
Earnings Call Transcript
3 weeks ago
Newspaper Publication
4 weeks ago
Newspaper Publication
4 weeks ago
Con Call audio link
4 weeks ago
Con Call audio link
4 weeks ago
Completion of USFDA Inspection
4 weeks ago
Completion of USFDA Inspection
4 weeks ago
Outcome of the Board Meeting
4 weeks ago
Outcome of the Board Meeting
4 weeks ago
Outcome of the Board Meeting
4 weeks ago
Outcome of the Board Meeting
4 weeks ago
Allotment of Equity Shares pursuant to exercise of Stock Options and grant of Stock Options to certain eligible employees of the Company
1 month ago
Allotment of Equity Shares pursuant to exercise of Stock Options and grant of Stock Options to certain eligible employees of the Company
1 month ago
Results Conference Call
1 month ago
Results Conference Call
1 month ago
Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30 June 2026
1 month ago
Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30 June 2026
1 month ago
Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
1 month ago
Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
1 month ago
Closure of Trading Window
2 months ago
Closure of Trading Window
2 months ago
Newspaper Publication
2 months ago
Newspaper Publication
2 months ago
Clarification on Volume Movement
2 months ago
Clarification on Volume Movement
2 months ago
The Exchange has sought clarification from Cohance Lifesciences Ltd on June 24 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months ago
The Exchange has sought clarification from Cohance Lifesciences Ltd on June 24 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.
2 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 months ago
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
2 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
2 months ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
2 months ago

Concalls & investor presentations

Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
Feb 2023
ConcallPresentation
Feb 2023
Nov 2022
ConcallPresentation
Nov 2022
May 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
Feb 2022
Nov 2021
Aug 2021
Jun 2021
ConcallPresentation
Jun 2021
Feb 2021
ConcallPresentation
Feb 2021
Oct 2020
ConcallPresentation
Oct 2020

Corporate Actions

Date
Type
Details
No data available.

Company details

Registered office

215 Atrium, C Wing, 8th Floor, 819-821 Andheri, Kurla Road, Chakala Andheri (East), Chakala Midc Mumbai Maharashtra PIN: 400093 Tel No: 022-61539999 Fax No: NULL Email: [email protected] Internet: www.cohance.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Umang Vohra, Chairman & Group CEO

Matangi Gowrishankar, Non Executive Independent Director

Vinod Rao, Non Executive Independent Director

K G Ananthakrishnan, Non Executive Independent Director

UB Pravin Rao, Non Executive Independent Director

Jai Shankar Krishnan, Non Executive Independent Director

Shweta Jalan, Non Executive Director

Pankaj Patwari, Non Executive Director

Vinod Padikkal, Non Executive Director

Himanshu Agarwal, Whole Time Director & Chief Financial Officer

Sisir K Mishra, Company Secretary & Compliance Officer

Details

BSE 543064

NSE COHANCE

ISIN INE03QK01018

Cohance Lifesciences Ltd Share Price Today

The Cohance Lifesciences Ltd share price today is ₹461.65. During the trading session, the Cohance Lifesciences Ltd share price opened at ₹462.00 and recorded an intraday high of ₹464.75 and a low of ₹458.65. Last closing price was ₹458.30. Over the past 52 weeks, the Cohance Lifesciences Ltd share price has ranged between ₹266.70 and ₹1,038.90. The current Cohance Lifesciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.